Background: Gastric cancer has always been one of the most
prevalent causes of cancer-related death and continues to be a major public
health issue. Gene alterations are required for the development of gastric
cancer, which are influenced by environmental and host factors.
Aim: This study aimed to explore the status of alteration of the three
genes-P53, HER2, and hMlH1 in gastric adenocarcinoa and to find out their
association with H. pylori infection and clinicopathological factors of the
operated patients.
Methods: This was a cross-sectional study. Endoscopically biopsied and
histopathologically confirmed as adenocarcinoma stomach patients were admitted
for surgical intervention in the department of Surgical Oncology in National
Institute of Cancer Research and Hospital Mohakhali, Dhaka, Bangladesh. For
genetic (P53 and hMLH1) study of the gastrectomized tissue DNA extraction and
optimization, we performed PCR amplification and DNA sequencing. HER2 was
studied by immunochemical technique. The results were matched with tumor
status, age and sex, smoking, and H. pylori antibody status of the patients to
find their association.
Results: The mean age of the patients was 52.91 (±13.94) years. Among the 45
patients selected for genetic tests, 12 aged 40 or more and 33 aged over 40.
Among the genes, 33(73.3%) in P53 and 17(37.7%) in hMLH1 were mutated and
11(24.2%) in HER2 were found to be overexpressed. Chi square and regression
analysis showed that they all had associations with H. pylori positivity (P
< 0.05, odds ratio >1). hMLH1 was associated with the location of the
tumor, smoking, sex, blood group, and age, and P53 was found to be affected by
extra salt intake, sex, blood group, and age of the patients (P ≤ 0.05). This study explored the relationship
of H. pylori infection with the genetic changes in cancer patients, which would
be a milestone in the cancer research in this country.
Conclusion: Genetic mutation was found in nearly all the patients with gastric
cancer, which was significantly associated with H. pylori infection. Mass
eradication of this organism might play a role in reducing cancer incidence in
Bangladesh.
Author(s) Details:
M. Mizanur Rahman,
National Institute of Cancer Research and Hospital, Mohakhali, Dhaka, Bangladesh.
Gazi Nurun Nahar Sultana,
Genetic Engineering and Biotechnology Research, Centre for Advanced Research in Sciences (CARS), University of Dhaka, Dhaka, Bangladesh.
Mohammed Abu Kawsar Sarker,
Department of General and Colorectal Surgery, Furness General Hospital, University Hospitals of Morecamb NHS Trust, Barrow-in-Furness, Lancaster, U.K.
Md. Monoar Hossain,
Department of Surgical Oncology, Khulna Medical College, Khulna, Bangladesh.
Mohd. Sahajadul Alam,
National Institute of Cancer Research and Hospital, Mohakhali, Dhaka, Bangladesh.
Md. Anisur Rahman,
Department of Gastroenterology, Popular Medical College Hospital, Dhanmondi, Dhaka, Bangladesh.
Abdul Ahad,
Department of Gastroenterology, Khulna Medical College, Khulna, Bangladesh.
Md. Monzurul Islam,
National Institute of Cancer Research and Hospital, Mohakhali, Dhaka, Bangladesh.
Rokeya Begum,
Genetic Engineering and Biotechnology Research, Centre for Advanced Research in Sciences (CARS), University of Dhaka, Dhaka, Bangladesh.
Please see the link here: https://stm.bookpi.org/ANUMS-V5/article/view/13309
No comments:
Post a Comment